The BC Cancer Library
Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Table of Contents:; 1. Immunotherapy administration; 2. Immunotherapy; 3. Cancer immunotherapy; 4. CAR T-cell therapy; 5. Cytokine release syndrome; 6. Developming infrastructure; 7. Immunotherapy toxicities; 8. Checkpoint inhibitors; 9. Toxicity managment; 10.Oncolytic viruses
| c.1 BC Cancer Agency VAN Library | Available | ||
| c.2 BC Cancer Agency VAN Library | Available | ||
| c.1 BC Cancer Agency KEL Library | Available |
Table of contents:; History of Cancer Immunotherapy -- Section I: Basic Principles of Tumor Immunology -- Section II: Cancer Immunotherapy Targets and Classes -- Section III: Immune Function in Cancer Patients -- Section IV: Disease-Specific Treatments and Outcomes -- Section V: Regulatory Aspects …
Table of Contents:; 1. HISTORY OF IMMUNOTHERAPY -- 2. PRINCIPLES OF IMMUNOLOGY AND IMMUNOTHERAPY -- 3. CYTOKINES IN IMMUNOTHERAPY -- 4. IMMUNE CHECKPOINT INHIBITORS -- 5. BACILLUS CALMETTE-GUÉRIN - 6. ORAL IMMUNOMODULATORY AGENTS --7. ACTIVE IMMUNITY: VACCINE THERAPY -- 8. PASSIVE/ADOPTIVE IMMUNOTH…
"Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia…
| c.1 BC Cancer Agency VAN Library | Available |
Overview; Diagnostic studies; Neurologic symptoms; Direct complications of cancer; Indirect complications of cancer; Complications of cancer therapy; Neurologic complications of specific malignancies
| c.1 BC Cancer Agency ARHCC Library | Available | ||
| c.1 BC Cancer Agency KEL Library | Available |
Table of Contents:; I OVERVIEW -- II DIAGNOSTIC STUDIES -- III NERVOUS SYSTEM INVOLVEMENT OF SYSTEMIC CANCERS -- IV NEUROLOGICAL COMPLICATIONS OF CANCER -- V NEUROLOGICAL COMPLICATIONS OF CANCER THERAPY -- NEUROLOGICAL COMPLICATIONS OF SPECIFIC MALIGNANCIES -- VII NEUROLOGICAL COMPLICATIONS IN LONG…
This publication represents the views and expert; opinions of an IARC Working Group on the; Evaluation of Carcinogenic Risks to Humans which met in Lyon , 3-10 June 2014.
| c.1 BC Cancer Agency VAN Library | Available |
Contents:; Introduction -- State health insurance exchanges: overview -- State insurance exchanges' impact on consumers -- Health literacy relevance to health insurance exchanges -- Current best practices in developing materials and communicating with consumers -- Reflections on lessons learned.
| c.1 BC Cancer Agency VIC Library | Available |
Contents:; 1. Mechanism of Chemotherapy in Cancer Treatment -- 2. Neutropenic Complications of Chemotherapy -- 3. Chemotherapy Induced Anemia -- 4. Cancer Treatment Related Thrombocytopenia -- 5. Oral Mucositis -- 6. Gastrointestinal Complications of Chemotherapy -- 7. Neurological Complications --…
